Twist Bioscience Corporation
Stock Details
Is it expensive?
Trailing P/E Ratio
-71.15
Forward P/E Ratio
-119.92
PEG Ratio
-9.39
-50.83
Price-to-Sales (TTM)
13.92
12.50
7.32
Market Cap
5.76B
5.58B
Is it profitable?
Net Profit Margin (TTM)
-19.85%
Gross Profit Margin
51.59%
Diluted EPS (TTM)
-1.32
-18.16%
409.48M
Is it growing?
19.30%
19.31%
Is it risky?
2.12
24.36
2.70
110.84M
Who owns it?
124.32%
1.20%
28.74%
62.15M
55.37M
Does it pay?
0.00%
0.00%
--
--
How much cash?
171.67M
-55.59M
-58.48M
2.76
- Price
- 92.53
- Percent Change
- +2.18 (2.41%)
- Previous Close
- 90.35
- Open
- 92.20
- Low
- 91.52
- High
- 94.67
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$92.53
From 52W Low
+297.12%
From 52W High
-12.27%
Today
+2.41%
1Y Change
+144.79%
6M
$40.03
3M
$57.41
1M
$80.79
Today
$92.53
From 52W Low
+297.12%
From 52W High
-12.27%
Today
+2.41%
1Y Change
+144.79%
6M
$40.03
3M
$57.41
1M
$80.79
Today
$92.53
Expensive
within its 1-year price range
$92.53
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+14.5%
3M
+61.2%
6M
+131.2%
1Y
+144.8%
Rate of Change (ROC)
Weakening
Price is rising, but slower than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Twist Bioscience Corporation
- Founded
- 2013
- CEO
- Emily Marine Leproust
- Employees
- 979
- Fiscal Year End
- Sep 30, 2025
- Address
681 Gateway Boulevard
South San Francisco
California
94080
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.twistbioscience.com
Indicators
Operating Cash Flow
-55.59M
Net Income
-81.28M
Mixed Signal
0.68
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |
Indicators
Operating Cash Flow
-55.59M
Net Income
-81.28M
Mixed Signal
0.68
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-71.15
Forward P/E Ratio
-119.92
PEG Ratio
-9.39
-50.83
Price-to-Sales (TTM)
13.92
12.50
7.32
Market Cap
5.76B
5.58B
Is it profitable?
Net Profit Margin (TTM)
-19.85%
Gross Profit Margin
51.59%
Diluted EPS (TTM)
-1.32
-18.16%
409.48M
Is it growing?
19.30%
19.31%
Is it risky?
2.12
24.36
2.70
110.84M
Who owns it?
124.32%
1.20%
28.74%
62.15M
55.37M
Does it pay?
0.00%
0.00%
--
--
How much cash?
171.67M
-55.59M
-58.48M
2.76
- Price
- 92.53
- Percent Change
- +2.18 (2.41%)
- Previous Close
- 90.35
- Open
- 92.20
- Low
- 91.52
- High
- 94.67
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$92.53
From 52W Low
+297.12%
From 52W High
-12.27%
Today
+2.41%
1Y Change
+144.79%
6M
$40.03
3M
$57.41
1M
$80.79
Today
$92.53
From 52W Low
+297.12%
From 52W High
-12.27%
Today
+2.41%
1Y Change
+144.79%
6M
$40.03
3M
$57.41
1M
$80.79
Today
$92.53
Expensive
within its 1-year price range
$92.53
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+14.5%
3M
+61.2%
6M
+131.2%
1Y
+144.8%
Rate of Change (ROC)
Weakening
Price is rising, but slower than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Twist Bioscience Corporation
- Founded
- 2013
- CEO
- Emily Marine Leproust
- Employees
- 979
- Fiscal Year End
- Sep 30, 2025
- Address
681 Gateway Boulevard
South San Francisco
California
94080
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.twistbioscience.com
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |